This is an analysis of Industry’s proposal of a contractual compensation agreement (a “Compact”), aimed as an alternative to the compensation funds and financial security requirements under discussion in the liability and redress negotiations. […]
|
||||||
|
A European biotech lobby is said to have inflated the figures on GM crop cultivation. […] How GM technology which has marginal relevance to developing countries justified itself as the solution to the development of poor countries. […] The biotech industry have developed two new techniques – artificial minichromosomes and transformed organelles. Are they safe? […] Organic agriculture has the potential to reduce, mitigate, and adapt to climate change impacts while remaining accessible to the billions of subsistence farmers around the world. […] This paper summaries key findings of studies which raises questions about the human health safety of Bt plants. […] Analysis by Prof Gilles-Eric Seralini of CRIIGEN on Mahyco’s data on Bt brinjal in India which raises serious questions about the methodologies used and the health and environment safety of the crop. […] Corporate control over commercial food, farming, livestock, health and the Earth’s remaining natural resources is increasing. […] A critical look at Golden Rice after 10 years of development. […] This paper summarizes some of the available evidence to demystify the productivity debate of organic agriculture and demonstrates that ecological agriculture is indeed productive, especially so in developing countries. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||